CYNERGISTEK INC/DE (CTEK) Fundamental Analysis & Valuation

NYSEARCA:CTEK • US23258P1057

1.25 USD
+0.02 (+1.63%)
At close: Aug 31, 2022
1.25 USD
0 (0%)
After Hours: 8/31/2022, 8:04:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CTEK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CTEK. CTEK was compared to 101 industry peers in the Health Care Providers & Services industry. The financial health of CTEK is average, but there are quite some concerns on its profitability. CTEK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. CTEK Profitability Analysis

1.1 Basic Checks

  • CTEK had negative earnings in the past year.
CTEK Yearly Net Income VS EBIT VS OCF VS FCFCTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M

1.2 Ratios

Industry RankSector Rank
ROA -55.8%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTEK Yearly ROA, ROE, ROICCTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -43.25%
PM (TTM) -61.88%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTEK Yearly Profit, Operating, Gross MarginsCTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTEK Health Analysis

2.1 Basic Checks

  • CTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CTEK has more shares outstanding
  • The debt/assets ratio for CTEK has been reduced compared to a year ago.
CTEK Yearly Shares OutstandingCTEK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
CTEK Yearly Total Debt VS Total AssetsCTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 0.99, we must say that CTEK is in the distress zone and has some risk of bankruptcy.
  • CTEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.99
ROIC/WACCN/A
WACC8.29%
CTEK Yearly LT Debt VS Equity VS FCFCTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.69 indicates that CTEK should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.69 indicates that CTEK should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
CTEK Yearly Current Assets VS Current LiabilitesCTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTEK Growth Analysis

3.1 Past

  • The earnings per share for CTEK have decreased strongly by -52.63% in the last year.
  • The Revenue has decreased by -2.26% in the past year.
  • CTEK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -22.99% yearly.
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16037.89%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y-8.55%
Revenue growth 5Y-22.99%
Sales Q2Q%1.76%

3.2 Future

  • Based on estimates for the next years, CTEK will show a very strong growth in Earnings Per Share. The EPS will grow by 34.71% on average per year.
  • Based on estimates for the next years, CTEK will show a quite strong growth in Revenue. The Revenue will grow by 17.89% on average per year.
EPS Next Y-23.1%
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
EPS Next 5Y34.71%
Revenue Next Year16.51%
Revenue Next 2Y18.47%
Revenue Next 3Y17.7%
Revenue Next 5Y17.89%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTEK Yearly Revenue VS EstimatesCTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CTEK Yearly EPS VS EstimatesCTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. CTEK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CTEK. In the last year negative earnings were reported.
  • Also next year CTEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTEK Price Earnings VS Forward Price EarningsCTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.57
CTEK Per share dataCTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • CTEK's earnings are expected to grow with 36.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.72%
EPS Next 3Y36.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CTEK Dividend Analysis

5.1 Amount

  • No dividends for CTEK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CTEK Fundamentals: All Metrics, Ratios and Statistics

CYNERGISTEK INC/DE

NYSEARCA:CTEK (8/31/2022, 8:04:02 PM)

After market: 1.25 0 (0%)

1.25

+0.02 (+1.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-15
Earnings (Next)11-09
Inst Owners5.97%
Inst Owner Change0%
Ins Owners2.94%
Ins Owner Change0%
Market Cap16.57M
Revenue(TTM)16.86M
Net Income(TTM)-10.43M
Analysts43.33
Price Target1.27 (1.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB N/A
EV/EBITDA -2.57
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.27
BVpS1.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -55.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -43.25%
PM (TTM) -61.88%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 0.99
F-Score3
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16037.89%
EPS Next Y-23.1%
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
EPS Next 5Y34.71%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y-8.55%
Revenue growth 5Y-22.99%
Sales Q2Q%1.76%
Revenue Next Year16.51%
Revenue Next 2Y18.47%
Revenue Next 3Y17.7%
Revenue Next 5Y17.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CYNERGISTEK INC/DE / CTEK FAQ

What is the ChartMill fundamental rating of CYNERGISTEK INC/DE (CTEK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTEK.


Can you provide the valuation status for CYNERGISTEK INC/DE?

ChartMill assigns a valuation rating of 2 / 10 to CYNERGISTEK INC/DE (CTEK). This can be considered as Overvalued.


What is the profitability of CTEK stock?

CYNERGISTEK INC/DE (CTEK) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CTEK stock?

The Earnings per Share (EPS) of CYNERGISTEK INC/DE (CTEK) is expected to decline by -23.1% in the next year.